In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this article, James Matera, DO, writes about a newer agent, finarenone, which is a nonsteroidal, selective mineralocorticoid receptor antagonist that can treat chronic kidney disease.
The first year of an infant’s life is perhaps the most important, as babies will triple their birth weight. That is why the US Dietary Guidelines for Americans and the American Academy of Pediatrics...
In this Pediatrics Top Paper, Brittany Perry, DO, writes about a study that compared the magnitude of positive depression screening results in adolescents across different approaches. She also writes about...
In this commentary, Michael J. Bloch, MD, writes about using nonpharmacological therapies, including endovascular renal denervation, to improve blood pressure control.
In this commentary, Maria Suarez-Almazor, MD, PhD, and Maryam Buni, MD, both from the University of Texas MD Anderson Cancer Center, highlight the current literature on the association between systemic...
Diet and lifestyle play a more prominent role in sleep than many people are aware. Often a few changes here and there can keep you from tossing and turning or asking for sleeping medication.
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
